Abstract
Veliparib and topotecan for patients with platinum-resistant or partially platinum-sensitive relapse of epithelial ovarian cancer with BRCA negative or unknown BRCA status
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have